Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)
- 21 February 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (6) , 1587-1590
- https://doi.org/10.1016/j.bmcl.2005.01.067
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Role of Novel Biological Therapies in Psoriatic ArthritisBioDrugs, 2003
- MK2 Targets AU-rich Elements and Regulates Biosynthesis of Tumor Necrosis Factor and Interleukin-6 Independently at Different Post-transcriptional LevelsJournal of Biological Chemistry, 2002
- MAP KinasesChemical Reviews, 2001
- Tumour Necrosis Factor-?? Blockers in Rheumatoid ArthritisBioDrugs, 2001
- MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesisNature Cell Biology, 1999
- The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid ArthritisDrugs, 1998